Schedule 13G ownership disclosure
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Security class unavailable · CUSIP: 539319103
Event date: 2021-12-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.7300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-009304
- Form type
- SC 13G
- Filer
- KRINSKY GLENN
- CIK
- CIK 1307773
- Filed
- Apr 07, 2022
- Reporting period
- Dec 17, 2021
- Description
- Schedule 13G beneficial ownership